United Kingdom
VascVersa Ltd is a regenerative medicine startup based in the United Kingdom, founded in 2018. The company's slogan "Restoring life where it's needed most" reflects its commitment to developing innovative therapies for patients. Spun out from Queen's University in Belfast, VascVersa aims to commercialize living medicines to reinvigorate patients' lives.
The company is focused on the health care industry and is leveraging Angicyte technology to develop new cell therapies for vascular regeneration. In August 2022, VascVersa secured a significant milestone with a £500.00K Seed Round investment from Halo Business Angel Network, Qubis, and Co-FundNI. This investment signifies a vote of confidence in the company's potential to revolutionize regenerative medicine.
VascVersa's innovative approach and strong backing from notable investors position it as a promising player in the regenerative medicine space, with the potential to make a significant impact on patients' lives.
